Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India.
Niyogi
S K
SK
Division of Microbiology and Clinical Medicine, National Institute of Cholera & Enteric Diseases, PO Beliaghata, Calcutta 700 010, India. niced@cal2.vsnl.net.in
Mitra
U
U
Dutta
P
P
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002648:Child; D003967:Diarrhea / Q000453:epidemiology / Q000382:microbiology; D004352:Drug Resistance, Microbial; D004405:Dysentery, Bacillary / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D005664:Furazolidone / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007194:India / Q000453:epidemiology; D009268:Nalidixic Acid / Q000494:pharmacology / Q000627:therapeutic use; D018571:Sentinel Surveillance; D016036:Seroepidemiologic Studies; D012703:Serotyping; D012760:Shigella / Q000145:classification* / Q000187:drug effects* / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D009268:Nalidixic Acid; D005664:Furazolidone